Pharmacology, Toxicology and Pharmaceutical Science
Rhesus Monkey
100%
Oxycodone
92%
Cannabidiol
85%
Cannabis
76%
Kappa Opiate Receptor Agonist
74%
Nalfurafine
63%
Pharmacokinetics
48%
Normal Human
46%
Pharmacodynamics
45%
Tetrahydrocannabinol
44%
Cannabinoid
39%
Triazole
37%
Ethanol
33%
Guanine Nucleotide Binding Protein
30%
Cannabis Sativa
28%
Mu Opiate Receptor Agonist
27%
Opiate
24%
Placebo
23%
Cytochrome P450
19%
Antinociception
19%
Behavioral Effect
17%
Drug Interaction
14%
Buprenorphine
14%
Duragesic
14%
Randomized Clinical Trial
14%
Alprazolam
14%
Naltrexone
14%
Oliceridine
14%
Limonene
14%
Cross Sectional Study
14%
Methadone
14%
Cosmetics
14%
Salvinorin A
11%
Kappa Opiate Receptor
9%
Side Effect
8%
Haplorhini
7%
Illicit Drug
7%
Disease
6%
Tetrahydrocannabivarin
5%
Keyphrases
Rhesus Monkey
57%
Cannabidiol
45%
Nalfurafine
42%
Oxycodone
38%
Self-administration
33%
Kappa Opioid Receptor Agonist
29%
Oxycodone Self-administration
28%
Sleeve Gastrectomy
28%
Cannabinoids
22%
Cannabis
16%
Rodent Models
16%
Δ9-tetrahydrocannabinol (Δ9-THC)
15%
Male Rats
14%
Oral Cannabis
14%
Metabolic Disease
14%
Progressive Ratio Schedule
14%
Kappa Opioid
14%
Rodents
14%
Urinary Excretion
14%
Pharmacodynamic Interactions
14%
Alprazolam
14%
Fetoplacental
14%
Naltrexone
14%
Caffeine
14%
Acute Administration
14%
STISIM
14%
Buprenorphine
14%
Alcohol Seeking
14%
Excretion Profile
14%
Human Laboratory Studies
14%
Rewarding Effect
14%
Baboon
14%
Surgical Menopause
14%
TRV130
14%
Observable Behaviors
14%
Vaporized Cannabis
14%
Variable Schedule
14%
Fentanyl
14%
Block Acquisition
14%
Pharmacokinetic Effects
14%
Analytical Toxicology
14%
Cannabis Users
14%
Immune Health
14%
Simultaneous Effects
14%
Actigraphy
14%
Methadone
14%
Oral Administration
14%
Cosmetic Products
14%
Hair Care
14%
Content Accuracy
14%
Medicine and Dentistry
Cannabis
40%
Sleeve Gastrectomy
28%
Cannabidiol
27%
Cannabinoid
20%
Placebo
17%
Water-Electrolyte Imbalance
14%
Tetrahydrocannabinol
14%
Cytochrome P450
14%
Drug Interaction
14%
Cross Sectional Study
14%
Tetrahydrocannabivarin
5%